Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 6427
The Licensor announced the completion of enrollment in our first pivotal Phase III clinical trial of pimavanserin in patients with Parkinson's disease psychosis. The Licensor has the option to co-promote pimavanserin in the United States. The Licensee will be responsible for all future costs associated with the development, manufacturing, and commercialization of pimavanserin in all indications with the exception of specified ongoing PDP studies, which will continue to be funded by the Licensor.
IPSCIO Record ID: 7782
IPSCIO Record ID: 6572
IPSCIO Record ID: 26360
The Licensor will retain certain rights to conduct development of the Licensed Products and an option to co-promote PRX002.
Thereafter, during the term of the License Agreement, the Licensor and the Licensee will work exclusively with each other to research and develop antibody products targeting alpha-synuclein.
A tiered, high single-digit to high double-digit royalties in the teens on ex-U.S. annual net sales, subject to certain adjustments. In the United States, the parties will share all development and commercialization.
The rights granted apply to the healthcare industry.